A bonus episode featuring a conversation with top executives at Johnson & Johnson Diabetes Care Companies (parent company of Animas). John Wilson is the Worldwide Vice President, Insulin Delivery and Krishna Venugopalan is the Worldwide Director, Research & Development, Insulin Delivery. They talk to Stacey about the significance of this approval, about Animas’s agreement with Dexcom and what’s coming next as that company moves forward with the Share, G5 and G6 versions of their CGM.